about
Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.Genetic epidemiology and preventive healthcare in multiethnic societies: the hemoglobinopathies.Evaluation of married haemoglobinopathic carrier couples for prevention of haemoglobinopathic birthsEvaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania.Evaluation of iron status in European adolescents through biochemical iron indicators: the HELENA Study.Spectrum of Hemoglobinopathies in West Bengal, India: A CE-HPLC Study on 10407 Subjects.Haemoglobinopathies in Greece: prevention programme over the past 35 yearsCarrier screening in preconception consultation in primary care.Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study.The prevention of thalassemia.Knowledge, Attitude and Practice of Carrier Thalassemia Marriage Volunteer in Prevention of Major Thalassemia.Haemoglobinopathy Awareness among Young Students in Turkey: Outcomes of a City-Wide Survey.Dynamics of sickle cell disease as one of the determinants of quality of lifePrevention of β Thalassemia in Northern Israel - a Cost-Benefit AnalysisClinico-Haematological Profile of Hereditary Haemolytic Anaemias in a Tertiary Health Care Hospital in South India.Lessons from thalassaemia screening in Iran.Understanding the roles of intrinsic disorder in subunits of hemoglobin and the disease process of sickle cell anemia.
P2860
Q33791764-579ABB5A-6485-41A9-AE69-07CFFBD12B1AQ33833974-E18E1E4D-30DC-4311-9DC8-64D69DCB0A64Q33974111-123229DB-758C-4AD5-9E35-0F8D01E08A2DQ34502334-101E4325-A884-4917-BFD2-A70A59F36D5EQ34590161-3597D2AD-7423-485A-A940-00D622F96B1BQ34626789-6BAFC1B3-0052-47E0-97ED-E56E55C921F5Q34766777-5FAE5D76-EC2C-4C66-9B81-B91094E28BFAQ35611099-7720E316-C37A-493B-AB27-2F3B7727D40FQ36164703-5473AAAE-7EF2-4131-9686-CBF69CC9D316Q36511357-C5291926-2F69-4AED-BFE0-5E5703FB6ABFQ36554628-4F3EA061-77D6-4570-BD94-8EFB692EEF4AQ36718248-07A1CADA-93C5-40AC-B163-DBFA023DF630Q37119180-562EAD84-1563-4395-854C-1A444039413FQ37212577-F0D51640-0F54-42C6-953D-5A8350E9ED94Q37663009-09C30972-B644-48FB-94E7-DAC9200E2B5AQ41176950-C2A93522-BAFF-484C-88EC-662101ECEAAAQ42424588-AA71C60A-A45A-4316-9601-A507AC7FF58AQ49759325-C4C2F5BF-3CB4-48BB-869C-34EB05ECDD1C
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Prevention and control of haemoglobinopathies.
@ast
Prevention and control of haemoglobinopathies.
@en
type
label
Prevention and control of haemoglobinopathies.
@ast
Prevention and control of haemoglobinopathies.
@en
prefLabel
Prevention and control of haemoglobinopathies.
@ast
Prevention and control of haemoglobinopathies.
@en
P2093
P2860
P1476
Prevention and control of haemoglobinopathies.
@en
P2093
Angastiniotis M
Boulyjenkov V
Englezos P
P2860
P304
P407
P577
1995-01-01T00:00:00Z